Geode Capital Management, LLC Kymera Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,053,224 shares of KYMR stock, worth $49.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,053,224

Previous 1,054,220 0.09%

Holding current value

$49.4 Million

Previous $31.5 Million 58.41%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.16 - $52.4 $30,039 - $52,190	-996 Reduced 0.09%	1,053,224 $49.8 Million
Q2 2024 Aug 09, 2024	BUY	$29.85 - $39.42 $2.64 Million - $3.49 Million	88,520 Added 9.17%	1,054,220 $31.5 Million
Q1 2024 May 13, 2024	BUY	$22.9 - $43.57 $1.95 Million - $3.71 Million	85,185 Added 9.67%	965,700 $38.8 Million
Q4 2023 Feb 13, 2024	BUY	$10.97 - $26.84 $507,779 - $1.24 Million	46,288 Added 5.55%	880,515 $22.4 Million
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $457,893 - $786,654	32,942 Added 4.11%	834,227 $11.6 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $458,214 - $714,323	20,456 Added 2.62%	801,285 $18.4 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $838,548 - $1.31 Million	33,758 Added 4.52%	780,829 $23.1 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $897,264 - $1.42 Million	45,849 Added 6.54%	747,071 $18.6 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $530,591 - $869,601	25,375 Added 3.75%	701,222 $15.3 Million
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $735,848 - $2.22 Million	52,077 Added 8.35%	675,847 $13.3 Million
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $131,598 - $241,127	3,728 Added 0.6%	623,770 $26.4 Million
Q4 2021 Feb 11, 2022	BUY	$49.91 - $65.56 $1.01 Million - $1.32 Million	20,172 Added 3.36%	620,042 $39.4 Million
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $12.3 Million - $17.2 Million	258,328 Added 75.64%	599,870 $35.2 Million
Q2 2021 Aug 13, 2021	BUY	$31.08 - $51.95 $4.81 Million - $8.05 Million	154,884 Added 82.98%	341,542 $16.6 Million
Q1 2021 May 12, 2021	SELL	$35.64 - $85.46 $187,573 - $449,775	-5,263 Reduced 2.74%	186,658 $7.25 Million
Q4 2020 Feb 12, 2021	BUY	$28.07 - $87.83 $4.37 Million - $13.7 Million	155,727 Added 430.26%	191,921 $11.9 Million
Q3 2020 Nov 13, 2020	BUY	$26.1 - $33.28 $944,663 - $1.2 Million	36,194 New	36,194 $1.17 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.57B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Kymera Therapeutics, Inc. Transaction History